BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,030 | $1,077 | $1,211 |
| - Cash | $29 | $32 | $67 | $95 |
| + Debt | $11 | $24 | $27 | $30 |
| Enterprise Value | – | $1,021 | $1,037 | $1,146 |
| Revenue | $28 | $25 | $24 | -$3 |
| % Growth | 10.4% | 6.2% | 799.2% | – |
| Gross Profit | $19 | $16 | $16 | $8 |
| % Margin | 66.9% | 64.6% | 65.9% | -241.6% |
| EBITDA | $3 | -$14 | $0 | $7 |
| % Margin | 9.1% | -56.4% | 0.7% | -197.1% |
| Net Income | $1 | -$16 | -$0 | $12 |
| % Margin | 2.2% | -62.3% | -1.9% | -363.9% |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 |
| % Growth | 103% | -3,373.7% | -103.7% | – |
| Operating Cash Flow | $6 | $7 | $2 | $2 |
| Capital Expenditures | -$3 | -$2 | -$0 | -$1 |
| Free Cash Flow | $3 | $6 | $2 | $1 |